Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report

This case represents the first documented successful treatment of ARDS induced by EGFR E19 mutated NSCLC using almonertinib. The favorable clinical response observed in this critically ill patient suggests that almonertinib may be a viable therapeutic option for managing severe complications in NSCLC. Further research is necessary to corroborate these findings and optimize dosage and toxicity management strategies for broader clinical application.

Authors

Institutions

Publication Details

Journal
BMC Pulmonary Medicine
Published
2024-09-27
DOI
https://doi.org/10.1186/s12890-024-03292-3
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report

Zhike Liang, Yawen Feng, Shuquan Wei, Wanna Tang et al.
BMC Pulmonary Medicine
Lung Cancer Treatments and Mutations
article

Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report

Zhike Liang, Yawen Feng, Shuquan Wei, Wanna Tang, Weinong Zhong, Cheng Sun, Yujun Li, Zihang Yan, Ziwen Zhao
article en

Abstract

This case represents the first documented successful treatment of ARDS induced by EGFR E19 mutated NSCLC using almonertinib. The favorable clinical response observed in this critically ill patient suggests that almonertinib may be a viable therapeutic option for managing severe complications in NSCLC. Further research is necessary to corroborate these findings and optimize dosage and toxicity management strategies for broader clinical application.

BMC Pulmonary MedicineVol. 24(1)
Jinan University (CN), Guangdong Medical College (CN), Guangdong Pharmaceutical University (CN), Guangzhou First People's Hospital (CN), Guangzhou Medical University (CN)
Good health and well-being
Openalex Percentile: Top 69%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Successful rapid improvement of acute respiratory distress syndrome induced by EGFR-mutated non-small cell lung cancer with almonertinib: a case report — Zhike Liang, Yawen Feng, et al. · BMC Pulmonary Medicine (2024) | TGRS Research Map | TGRS